GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lantheus Holdings Inc (NAS:LNTH) » Definitions » Cyclically Adjusted PB Ratio

Lantheus Holdings (Lantheus Holdings) Cyclically Adjusted PB Ratio : 66.28 (As of May. 01, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Lantheus Holdings Cyclically Adjusted PB Ratio?

As of today (2024-05-01), Lantheus Holdings's current share price is $67.6025. Lantheus Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $1.02. Lantheus Holdings's Cyclically Adjusted PB Ratio for today is 66.28.

The historical rank and industry rank for Lantheus Holdings's Cyclically Adjusted PB Ratio or its related term are showing as below:

LNTH' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 51.84   Med: 222.77   Max: 1759
Current: 65.85

During the past years, Lantheus Holdings's highest Cyclically Adjusted PB Ratio was 1759.00. The lowest was 51.84. And the median was 222.77.

LNTH's Cyclically Adjusted PB Ratio is ranked worse than
99.54% of 657 companies
in the Drug Manufacturers industry
Industry Median: 1.8 vs LNTH: 65.85

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lantheus Holdings's adjusted book value per share data for the three months ended in Dec. 2023 was $11.907. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.02 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Lantheus Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Lantheus Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lantheus Holdings Cyclically Adjusted PB Ratio Chart

Lantheus Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 60.70

Lantheus Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1,702.09 228.84 60.70

Competitive Comparison of Lantheus Holdings's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Lantheus Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lantheus Holdings's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lantheus Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lantheus Holdings's Cyclically Adjusted PB Ratio falls into.



Lantheus Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Lantheus Holdings's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=67.6025/1.02
=66.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lantheus Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Lantheus Holdings's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=11.907/129.4194*129.4194
=11.907

Current CPI (Dec. 2023) = 129.4194.

Lantheus Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201403 -8.660 99.695 -11.242
201406 -8.689 100.560 -11.183
201409 -8.736 100.428 -11.258
201412 -8.752 99.070 -11.433
201503 -9.045 99.621 -11.751
201506 -6.447 100.684 -8.287
201509 -6.262 100.392 -8.073
201512 -6.102 99.792 -7.914
201603 -5.735 100.470 -7.387
201606 -5.475 101.688 -6.968
201609 -3.392 101.861 -4.310
201612 -2.898 101.863 -3.682
201703 -2.728 102.862 -3.432
201706 -2.334 103.349 -2.923
201709 -2.078 104.136 -2.583
201712 0.617 104.011 0.768
201803 0.886 105.290 1.089
201806 1.163 106.317 1.416
201809 1.443 106.507 1.753
201812 1.846 105.998 2.254
201903 2.144 107.251 2.587
201906 2.363 108.070 2.830
201909 2.579 108.329 3.081
201912 2.920 108.420 3.486
202003 2.979 108.902 3.540
202006 7.717 108.767 9.182
202009 7.683 109.815 9.055
202012 7.689 109.897 9.055
202103 7.832 111.754 9.070
202106 7.518 114.631 8.488
202109 7.380 115.734 8.253
202112 6.856 117.630 7.543
202203 7.523 121.301 8.026
202206 8.255 125.017 8.546
202209 9.273 125.227 9.583
202212 6.623 125.222 6.845
202303 6.524 127.348 6.630
202306 8.078 128.729 8.121
202309 10.205 129.860 10.170
202312 11.907 129.419 11.907

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lantheus Holdings  (NAS:LNTH) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Lantheus Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Lantheus Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lantheus Holdings (Lantheus Holdings) Business Description

Traded in Other Exchanges
Address
201 Burlington Road, South Building, Bedford, MA, USA, 01730
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Executives
Andrea Sabens officer: Chief Accounting Officer C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862
Marshall Robert J. Jr. officer: CFO and Treasurer C/O LANTHEUS MEDICAL IMAGING, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862
Paul Blanchfield officer: Chief Commercial Officer C/O LANTHEUS HOLDINGS, INC., 331, NORTH BILLERICA MA 01862
Mary Anne Heino director, officer: CEO and President C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA NY 01862
Daniel Niedzwiecki officer: See Remarks C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862
Minnie Baylor-henry director C/O SCPHARMACUETICALS, INC., 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA 01803
Etienne Montagut officer: See Remarks C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862
Sam R Leno director C/O BOSTON SCIENTIFIC CORPORATION, ONE BOSTON SCIENTIFIC PLACE, NATICK MA 01760
Brian A Markison director 501 FIFTH STREET, BRISTOL TN 37620
Jean-claude Provost officer: Chief Medical Officer C/O LANTHEUS HOLDINGS, INC., 201 BURLINGTON RD, SOUTH BUILDING, BEDFORD MA 01730
Julie Mchugh director C/O IRONWOOD PHARMACEUTICALS, INC., 100 SUMMER STREET, SUITE 2300, BOSTON MA 02110
Gerard Ber director C/O Y-MABS THERAPEUTICS, INC., 230 PARK AVENUE, 33RD FLOOR, NEW YORK NY 10169
Carol Walker officer: Senior Vice President, Quality C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862
Ying Vivian Yao officer: Chief Human Resources Officer C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862
John J. Bolla director C/O LANTHEUS MEDICAL IMAGING, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA MA 01862